Preclinical data support SLS009 as a monotherapy or in combination with venetoclax for the treatment of T-PLL, a rare and highly aggressive form of mature T-cell leukemia ...

The results highlight an in vivo patient-derived xenograft (PDX) model of relapsed/refractory T-PLL that reproduced key human clinicopathological features of the disease. In this model, SLS009 ...

Mid Valley High School grad Eddie Kaufman, a star on the baseball field and golf course, and among family and friends, died ...

have successfully treated a 31-year-old engineer with high-risk Pre-B Acute Lymphoblastic Leukemia (ALL) using CAR-T cell therapy. This marks the hospital's first adult leukemia patient to receive the ...

Haplo-cord HCT offered improved 2-year OS (72.7% vs 61.0%) and DFS (67.0% vs 49.6%) compared with haplo HCT alone.

Roanoke student and baseball player Eddie Kaufman passed Tuesday after a courageous battle with T-cell acute lymphoblastic leukemia, the Roanoke College Athletics Facebook page has reported.

Bristol Myers BMY recently announced that it will acquire privately held biotechnology company Orbital Therapeutics for $1.5 ...

A 12-year-old girl diagnosed with acute lymphoblastic leukemia was successfully treated for the first time with CAR-T immune cell therapy by doctors at the Ho Chi Minh City Blood Transfusion and ...

Orca-T is an allogeneic T-cell immunotherapy that consists of purified regulatory T-cells, hematopoietic stem cells and conventional T-cells derived from peripheral blood.

Orca Bio, a late-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...

Eddie Kaufman played hard on the field, but fought even harder off the diamond before losing his fight with leukemia at the ...